全文获取类型
收费全文 | 23710篇 |
免费 | 1787篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 473篇 |
妇产科学 | 329篇 |
基础医学 | 3295篇 |
口腔科学 | 422篇 |
临床医学 | 2780篇 |
内科学 | 4276篇 |
皮肤病学 | 225篇 |
神经病学 | 2280篇 |
特种医学 | 844篇 |
外科学 | 3102篇 |
综合类 | 278篇 |
一般理论 | 29篇 |
预防医学 | 3031篇 |
眼科学 | 690篇 |
药学 | 1806篇 |
中国医学 | 35篇 |
肿瘤学 | 1497篇 |
出版年
2023年 | 142篇 |
2022年 | 258篇 |
2021年 | 521篇 |
2020年 | 331篇 |
2019年 | 463篇 |
2018年 | 557篇 |
2017年 | 417篇 |
2016年 | 465篇 |
2015年 | 625篇 |
2014年 | 798篇 |
2013年 | 1052篇 |
2012年 | 1765篇 |
2011年 | 1808篇 |
2010年 | 1027篇 |
2009年 | 953篇 |
2008年 | 1585篇 |
2007年 | 1727篇 |
2006年 | 1598篇 |
2005年 | 1596篇 |
2004年 | 1554篇 |
2003年 | 1496篇 |
2002年 | 1255篇 |
2001年 | 265篇 |
2000年 | 209篇 |
1999年 | 248篇 |
1998年 | 274篇 |
1997年 | 178篇 |
1996年 | 179篇 |
1995年 | 133篇 |
1994年 | 148篇 |
1993年 | 111篇 |
1992年 | 147篇 |
1991年 | 116篇 |
1990年 | 119篇 |
1989年 | 120篇 |
1988年 | 113篇 |
1987年 | 132篇 |
1986年 | 100篇 |
1985年 | 103篇 |
1984年 | 83篇 |
1983年 | 81篇 |
1982年 | 60篇 |
1981年 | 68篇 |
1980年 | 52篇 |
1979年 | 58篇 |
1978年 | 52篇 |
1977年 | 47篇 |
1976年 | 42篇 |
1975年 | 34篇 |
1972年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
2.
3.
4.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
5.
6.
7.
G E Davies A V Thompson Z Niewola G E Burrows E L Teasdale D J Bird D A Phillips 《Occupational and environmental medicine》1983,40(4):442-449
Twenty four volunteers who had been allergic to laboratory animals for some years were examined by means of a questionnaire paying particular attention to symptoms associated with rats and by serological and skin tests with extracts of rat urine (retrospective study). Nasal and eye symptoms were reported by 21 and 16 individuals respectively: 13 had asthma. Positive skin tests and high levels of specific IgE antibody to rat urine extract were found in 17 of the more severely affected individuals and this group included 12 of those with asthma. Latent periods of work with animals before symptoms appeared varied from 0.5 to 12 years. Also 148 individuals were studied during their first year of work with animals (prospective study). Symptoms developing during the year were reported by 15%, asthma by 2%. IgE antibody levels to rat urine were raised in 40% of affected and 6% of the unaffected individuals but there was no significant correlation between symptoms and either antibody levels or positive skin tests. Allergic symptoms developing during the first year of postemployment were, on the whole, much milder than those seen in the retrospective study. A tentative conclusion is that most individuals who become allergic to laboratory animals develop the condition in a mild form during their first year of employment but it appears probable that atopic individuals, although having an equal chance of developing allergy as compared with non-atopic individuals, may eventually progress to a more severe form of the disease. 相似文献
8.
9.
Chris Giles 《Canadian Medical Association journal》2002,167(7):786-787
10.